Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | RVNC | XOMA | ||
| Company | Acelyrin Inc | Revance Therapeutics | Xoma Royalty Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.20 | 3.07 | 26.42 | ||
| High | 3.20 | 3.08 | 27.13 | ||
| Low | 3.06 | 3.07 | 26.42 | ||
| Last | 3.17 | 3.08 | 27.13 | ||
| Change | -0.01 | +0.01 | +0.51 | ||
| % Change | -0.31% | +0.33% | +1.92% | ||
| Volume | 244,221 | 407,356 | 13,770 | ||
| 20-Day Average Volume | 788,216 | 3,562,978 | 35,174 | ||
| Previous Close | 3.18 | 3.07 | 26.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.83 | 3.39 | 29.36 | ||
| 20-Day Raw Stochastic | 6.20% | 5.83% | 24.76% | ||
| 20-Day Relative Strength | 31.26% | 35.03% | 43.38% | ||
| Weighted Alpha | -64.05 | -72.19 | +32.11 | ||
| Today's Opinion | 72% Sell | 88% Sell | 8% Buy | ||
| Previous Opinion | 72% Sell | 88% Sell | 8% Sell | ||
| Last Month's Opinion | 40% Sell | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.43% since 12/17/24 | +0.33% since 12/17/24 | -0.04% since 12/17/24 | ||
| Low | 3.06 on 12/24/24 | 3.06 on 12/23/24 | 24.54 on 12/20/24 | ||
| High | 3.60 on 12/18/24 | 3.09 on 12/19/24 | 27.51 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | -32.55% since 11/22/24 | -17.43% since 11/22/24 | -10.17% since 11/22/24 | ||
| Low | 3.06 on 12/24/24 | 3.01 on 12/09/24 | 24.54 on 12/20/24 | ||
| High | 5.03 on 11/25/24 | 4.21 on 11/27/24 | 35.00 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | -35.44% since 09/24/24 | -43.95% since 09/24/24 | +0.78% since 09/24/24 | ||
| Low | 3.06 on 12/24/24 | 3.01 on 12/09/24 | 24.54 on 12/20/24 | ||
| High | 6.52 on 10/17/24 | 6.09 on 10/28/24 | 35.00 on 11/27/24 | ||
| 6-Month | |||||
| %Chg | -21.34% since 06/24/24 | +19.84% since 06/24/24 | +5.03% since 06/24/24 | ||
| Low | 3.06 on 12/24/24 | 2.30 on 06/26/24 | 21.86 on 06/26/24 | ||
| High | 7.25 on 07/17/24 | 6.65 on 08/19/24 | 35.00 on 11/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 319,037 | 320,477 | 313,663 | ||
| Shares Outstanding, K | 100,326 | 104,390 | 11,783 | ||
| Annual Sales | 0 | 234,040,000 | 4,760,000 | ||
| Annual Net Income | -381,640,000 | -323,990,000 | -40,830,000 | ||
| Last Quarter Sales | 0 | 59,880,000 | 7,200,000 | ||
| Last Quarter Net Income | -48,550,000 | -38,120,000 | -17,240,000 | ||
| 60-Month Beta | 1.63 | 0.82 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 11/13/24 | -0.37 on 11/07/24 | -0.39 on 11/07/24 | ||
| Latest Earnings Date | 11/13/24 | 11/13/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||